Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$846B
sum of reported positions
Reported positions
626
Changes vs prior quarter
584
70 new · 57 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 325 measured positions in 8 quarters, the typical new or larger position finished −1.3 pts against the S&P 500 and 47% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $733B | $846B |
| Positions | 613 | 626 |
| Biggest line | — | Broadcom 5% |
| 133M |
| $24.1B |
| 2.8% |
| 40.9M | $23B | 2.7% |
| 109M | $21.8B | 2.6% |
| 55.1M | $20.6B | 2.4% |
| 45.7M | $19.2B | 2.3% |
| 15.9M | $19.1B | 2.3% |
| 34.4M | $16.4B | 1.9% |
| 42.5M | $15B | 1.8% |
| 61.2M | $14.6B | 1.7% |
| 45.3M | $13.7B | 1.6% |
| 26.1M | $13B | 1.5% |
| 29.9M | $12.4B | 1.5% |
| 39.3M | $11.4B | 1.3% |
| 16.6M | $10.6B | 1.3% |
| 29.1M | $10.5B | 1.2% |
| 28.3M | $9.7B | 1.1% |
| 91.5M | $9.35B | 1.1% |
| 218M | $8.62B | 1.0% |
| 75M | $7.75B | 0.9% |
| 55.2M | $7.71B | 0.9% |
| 3.73M | $7.41B | 0.9% |
| 27.1M | $7.38B | 0.9% |
Enphase Energy (ENPH)
563K shares
Winnebago Industries, Inc. (WGO)
851K → 875K shares (+3%)
Charter Communications (CHTR)
84K → 192K shares (+128%)
Insulet Corporation (PODD)
168K → 173K shares (+3%)
Essex Property Trust (ESS)
75K → 90K shares (+20%)
Generac (GNRC)
81K → 88K shares (+8%)
Semtech (SMTC)
158K shares
TransMedics Group, Inc. (TMDX)
374K → 385K shares (+3%)
Axt (AXTI)
343K shares
Rhythm Pharmaceuticals (RYTM)
116K → 221K shares (+91%)
Snap (SNAP)
5.53M shares
PG&E Corporation (PCG)
1M → 1.38M shares (+38%)
PROG Holdings, Inc. (PRG)
497K shares
Rapport Therapeutics (RAPP)
537K → 552K shares (+3%)
Datadog (DDOG)
9,578 → 88K shares (+819%)
Applied Aerospace & Defense (AADX)
1M shares
Veeva Systems (VEEV)
870K → 127K shares (−85%)
Dpc Holdings (DPC)
451K shares
Ars Pharmaceuticals (SPRY)
2.75M shares
Tpg (TPG)
2.98M → 535K shares (−82%)
Caris Life Sciences (CAI)
1.18M → 1.21M shares (+3%)
Cytokinetics (CYTK)
242K → 249K shares (+3%)
Medline (MDLN)
4.31M → 536K shares (−88%)
Century Aluminum Company (CENX)
391K shares
Artisan Partners Asset Management, Inc. (APAM)
1.06M → 509K shares (−52%)
